Get started
UiPath, Inc.UiPath, Inc.UiPath, Inc.

UiPath, Inc.

No trades
See on Supercharts
Overview Financials News
Ideas
Discussions Technicals Forecast Seasonals Options

PATH trade ideas

PATH UiPath Investment Idea - Main Post$PATH I think this is a great business that can potentially double or triple over the next few years. UiPath is a company that provide RPA SaaS tools that help. Lets Analyse the company slowly: Business Model , what they are all about: - RPA mean Robotic Process Automation ; this is a software system that emulate human action repetitive tasks, software robots can do things like understand what’s on a screen, complete the right keystrokes, navigate systems, identify and extract data, and perform a wide range of defined actions. But software robots can do it faster and more consistently than people, without the need to get up and stretch or take a coffee break. UiPath uses artificial intelligence to analyze tasks while workers are doing them, identifying opportunities for users to automate certain processes after seeing them done only a few times. The platform includes specific tools to get ideas from employees on what to automate, to find patterns in workflows that are ripe for automation, and to build end-to-end process maps that improve key performance metrics. Users can often develop their own automation tools with the help of UiPath's robot-building tools, and the platform handles key issues like cybersecurity, compliance, and IT governance. UiPath even offers training and other resources to help users become as productive as possible. Founders and the management: - Daniel Dines: he is a Romanian Businessman, taught himself programing at young age and over time he was able to have a job in Microsoft, being in professional work environment really provide a positive sign about the person future, he later took Masters degree in mathematics and computer science (another formal education that show commitment and discipline that most of people lack). Another positive characteristics of Daniel is he is an avid reader and wanted to be an author previously, this impact on how deeply he know about the industry he is working in and the level of involvement can be. They have solid management too, for that visit this page: www.uipath.com I went through key people and checked their history and everything about them seem positive. Partners: - After having a look at partnerships that the company have, this is definitely going to scale in the future. Partners include: - EY, Delloitte, Pwc (three of the big 4!), IBM, Accenture. Just to name few because they have 75 pages on their website showing their partners. EY is an audit company and they adopted UiPath software globally, you do not expect two of the big fours to act and adopt a software without providing a real value for them. I have been personally reading since 2014 that audit firms are pushing to automate process in order to have more time to focus on products and procedures that are relevant to value adding services to customers. Just google it. Share price: - Even though the business model and market industry show potential growth and expansion, the company stock never went up that much, even in IPO period the price went up to around $90 per share and it went down now for less than half. The reason can be due to the broader macro-economic situation. It is important to look at the price range to enter from, I personally see downside potential to reach around 35 in the current market conditions, if the Federal reserve increase interest rate also in the first quarter 2022 as they have just indicated, we can also expect the stock price to fall further more. I will be monitoring the price of the company and then I will be buying in small bulks every time the stock go down until I make the company become 2% of my overall portfolio. Competition Risk: Also, UiPath's partner-focused business model has worked well, but we'll be looking to see how potential competitors respond to its success. If UiPath were to lose key partners for competitive reasons, it could potentially change the industry landscape adversely for the company. Competitors mainly include Blueprism and Automation Anywhere. Financial Information: A quick look at the company financial information, we can find the followings: - A sign of expansion and growth: revenue is growing YoY - Making operating profit - the company is still making net loss, even though its balance sheet show great cashflow numbers, the company still showing accumulated deficit, even though this is a normal thing for new companies that are spending money on sales and marketing, yet we need to know when the company will show a positive sign or reversing net loss effect. Overall the company is a solid one. I will not be buying now but definitely a one in the watchlist
NYSE:PATHLong
by AgentHK
Bottom of the barrel trend. Only up from here. This company recently IPO'd (went public) and is in the robotic process automation industry which enhances companies’ workflows through automation. In essence, the company saves, time and resources of the employees by streamlining processes. Technically speaking, the company has been on a strong downtrend yet recently it has consolidated and has bounced off support various times. Additionally, the risk/reward is very compelling for this stock due to the fact that it has seen highs of the high 80s (+30%) range, yet the downside to low 60's or 10%. Furthermore, the stock has been getting purchased from the lucrative ARK fund. This can cause quite the stir amongst the fiance media community and further enhance its upside potential. More analysis on my profile.
NYSE:PATHLong
by howdydany
3
UiPath UiPath is a global software company for robotic process automation. Reviewing the 1H chart, there may be an attempt at a bullish reversal. - Price just below the pivot: $70.25 needs to be cleared. - 1H RSI breaking above resistance to a 1-month high. Note: It would surprise me to see a small flush lower before we get an 'official' bullish reversal (early lock-up expiry has been putting pressure on the shares). Buy here ($69.75) or better. Stop: $67.20 Target Range: $76.00-$77.60
NYSE:PATHLong
by LD_Perspectives